Routine buyback disclosure with no material new information. The pace of repurchases (≈1.05M shares/week) is steady. No actionable trading signal; monitor for any change in pace or program suspension.
Price Chart
Executive Summary
Novo Nordisk filed a 6-K disclosing ongoing B-share repurchases under a DKK 15 billion program. Since February 4, 2026, the company has repurchased 22.0 million B shares for DKK 5.9 billion at an average price of DKK 268.02 per share. The filing is a routine transaction update with no material new information that would move the stock.
Key Facts
- Total buyback program of up to DKK 15 billion over 12 months starting February 4, 2026
- Sub-program initiated May 6, 2026 for up to DKK 11.2 billion through February 1, 2027
- As of June 26, 2026: 22,009,179 B shares repurchased for DKK 5,898,848,910 (avg DKK 268.02/share)
- Novo Nordisk holds 39,194,480 B shares as treasury shares, representing 0.9% of share capital
- Total A and B shares outstanding: 4,465,000,000
- Weekly transactions disclosed: 200,000-220,000 B shares per day at DKK 291-315 average price
Financial Impact
DKK 5.9 billion deployed in buybacks year-to-date; remaining capacity of approximately DKK 9.1 billion under the 12-month program
Risk Factors
- No new risks identified from this filing; share repurchase is being executed as previously announced
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-004353 |
| Document: 0001171843-26-004353-index-headers.html | 0001171843-26-004353 |
| Document: 0001171843-26-004353-index.html | 0001171843-26-004353 |
| Document: 0001171843-26-004353.txt | 0001171843-26-004353 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | $39.00 | awaiting T+20 | — | $38.67 (−0.85%) |
Oct 19, 2026 8d ago | 6-K | $38.42 | awaiting T+20 | — | $38.67 (+0.64%) |
Oct 13, 2026 14d ago | 6-K | $38.06 | awaiting T+20 | — | $38.67 (+1.59%) |
Oct 6, 2026 21d ago | 6-K | $37.53 | awaiting T+20 | — | $38.67 (+3.02%) |
Sep 28, 2026 29d ago | 6-K | $38.71 $38.95 | ▲ +0.61% | ▲ +0.64% | $38.67 (−0.12%) |
Sep 23, 2026 4w ago | Court Ruling | $38.62 $39.43 | ▲ +2.10% | ▲ +2.52% | $38.67 (+0.12%) |
Sep 21, 2026 5w ago | 6-K | $39.80 $38.42 | ▼ −3.47% | ▼ −2.56% | $38.67 (−2.85%) |
Sep 17, 2026 5w ago | 6-K | $43.19 $39.22 | ▼ −9.19% | ▼ −10.40% | $38.67 (−10.48%) |
Sep 15, 2026 6w ago | 6-K | $42.53 $38.06 | ▼ −10.51% | ▼ −13.23% | $38.67 (−9.09%) |
Sep 9, 2026 6w ago | 6-K | $44.56 $38.26 | ▼ −14.14% | ▼ −16.08% | $38.67 (−13.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers